Neuren Pharmaceuticals Ltd Capital Reinvestment Ratio
Neuren Pharmaceuticals Ltd capital reinvestment ratio. Neuren Pharmaceuticals Ltd (NEU) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$128.31 Million) in capital expenditures (AU$5.00K). Check NEU capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Neuren Pharmaceuticals Ltd (2018–2023)
Capital reinvestment ratio of Neuren Pharmaceuticals Ltd from 2018 to 2023. This chart tracks Neuren Pharmaceuticals Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore NEU net assets growth trend to track the company's year-over-year net asset growth rate.
Neuren Pharmaceuticals Ltd Capital Reinvestment Ratio by Year (2018–2023)
Neuren Pharmaceuticals Ltd capital reinvestment ratio by year from 2018 to 2023. For the full cash flow conversion analysis, see NEU cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.00x | AU$184.93 Million | AU$40.00K | ▼ -95.9% |
| 2022 | 0.01x | AU$3.60 Million | AU$19.00K | ▲ +181.9% |
| 2018 | 0.00x | AU$6.41 Million | AU$12.00K | — |